South Africa pauses AstraZeneca vaccine rollout after study shows it offers less protection against variant
South African health officials said Sunday they're pausing the country's rollout of AstraZeneca's coronavirus vaccine after a study showed it offered reduced protection from the Covid-19 variant first identified there.